# DeFi Development Corp.: financial statements, quarterly

DFDV · Nasdaq · CIK 1805526 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dfdv.md) · [Financials](/companies/dfdv/financials.md) · [Filings](/companies/dfdv/filings.md) · [Insiders](/companies/dfdv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dfdv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.6](/filings/0001575872-24-001133.md) | [0.4 d](/filings/0001013762-25-003260.md) | [0.4](/filings/0001575872-24-000532.md) | [0.4](/filings/0000950170-25-108479.md) | [0.6](/filings/0001193125-25-286660.md) | [0.6 d](/filings/0001805526-26-000006.md) | [0.3](/filings/0001805526-26-000040.md) | [2.0](/filings/0001805526-26-000055.md) | [4.6](/filings/0001193125-25-286660.md) | [4.5 d](/filings/0001805526-26-000006.md) | [2.7](/filings/0001805526-26-000040.md) | [3.3](/filings/0001805526-26-000055.md) |
| Cost of revenue | $m | [0.0](/filings/0001575872-24-001133.md) | not reported | [0.0](/filings/0001575872-24-000532.md) | [0.0](/filings/0000950170-25-108479.md) | [0.0](/filings/0001193125-25-286660.md) | [0.0 d](/filings/0001805526-26-000006.md) | [0.0](/filings/0001805526-26-000040.md) | [0.0](/filings/0001805526-26-000055.md) | [0.1](/filings/0001193125-25-286660.md) | [0.1 d](/filings/0001805526-26-000006.md) | [0.1](/filings/0001805526-26-000040.md) | [0.0](/filings/0001805526-26-000055.md) |
| Gross profit | $m | [0.6](/filings/0001575872-24-001133.md) | not reported | [0.4](/filings/0001575872-24-000532.md) | [0.4](/filings/0001575872-24-000905.md) | [0.6](/filings/0001575872-24-001133.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [0.2](/filings/0001575872-24-001133.md) | [0.3 d](/filings/0001013762-25-003260.md) | [0.2](/filings/0001213900-25-042977.md) | [0.2](/filings/0000950170-25-108479.md) | [0.2](/filings/0001193125-25-286660.md) | [0.2 d](/filings/0001805526-26-000006.md) | [0.2](/filings/0001805526-26-000040.md) | [0.3](/filings/0001805526-26-000055.md) | [0.3](/filings/0001193125-25-286660.md) | [0.4 d](/filings/0001805526-26-000006.md) | [0.1](/filings/0001805526-26-000040.md) | [0.1](/filings/0001805526-26-000055.md) |
| Operating income | $m | [(1.6)](/filings/0001575872-24-001133.md) | [(1.2) d](/filings/0001013762-25-003260.md) | [(1.0)](/filings/0001213900-25-042977.md) | [(0.9)](/filings/0000950170-25-108479.md) | [(0.5)](/filings/0001193125-25-286660.md) | [(0.7) d](/filings/0001805526-26-000006.md) | [(0.9)](/filings/0001805526-26-000040.md) | [17.2](/filings/0001805526-26-000055.md) | [72.1](/filings/0001193125-25-286660.md) | [(125) d](/filings/0001805526-26-000006.md) | [(55.2)](/filings/0001805526-26-000040.md) | [(22.8)](/filings/0001805526-26-000055.md) |
| Interest expense | $m | not reported | not reported | [(0.1)](/filings/0001213900-25-042977.md) | not reported | not reported | not reported | [0.0](/filings/0001805526-26-000040.md) | [0.8](/filings/0001805526-26-000055.md) | [2.9](/filings/0001193125-25-286660.md) | [5.2 d](/filings/0001805526-26-000006.md) | [2.7](/filings/0001805526-26-000040.md) | [3.7](/filings/0001805526-26-000055.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001805526-26-000040.md) | [1.2](/filings/0001805526-26-000055.md) | [17.9](/filings/0001193125-25-286660.md) | [(19.1) d](/filings/0001805526-26-000006.md) | [0.0](/filings/0001805526-26-000040.md) | [0.0](/filings/0001805526-26-000055.md) |
| Net income | $m | [(1.6)](/filings/0001575872-24-001133.md) | [(1.2) d](/filings/0001013762-25-003260.md) | [(1.0)](/filings/0001193125-25-286660.md) | [(0.8)](/filings/0001193125-25-286660.md) | [(0.5)](/filings/0001193125-25-286660.md) | [(0.5) d](/filings/0001805526-26-000006.md) | [(0.8)](/filings/0001805526-26-000055.md) | [15.4](/filings/0001805526-26-000055.md) | [56.0](/filings/0001805526-26-000006.md) | [(144) d](/filings/0001805526-26-000006.md) | [(83.4)](/filings/0001805526-26-000055.md) | [(27.3)](/filings/0001805526-26-000055.md) |
| Diluted EPS | $ per share | [(0.17)](/filings/0001575872-24-001133.md) | not reported | [(0.70)](/filings/0001213900-25-042977.md) | [(0.08)](/filings/0000950170-25-108479.md) | [(0.05)](/filings/0001193125-25-286660.md) | not reported | [(0.08)](/filings/0001805526-26-000040.md) | [0.84](/filings/0001805526-26-000055.md) | [1.95](/filings/0001805526-26-000006.md) | not reported | [(3.18)](/filings/0001805526-26-000040.md) | [(1.00)](/filings/0001805526-26-000055.md) |
| Basic EPS | $ per share | [(0.17)](/filings/0001575872-24-001133.md) | not reported | [(0.70)](/filings/0001213900-25-042977.md) | [(0.08)](/filings/0000950170-25-108479.md) | [(0.05)](/filings/0001193125-25-286660.md) | not reported | [(0.08)](/filings/0001805526-26-000040.md) | [1.09](/filings/0001805526-26-000055.md) | [2.70](/filings/0001805526-26-000006.md) | not reported | [(3.18)](/filings/0001805526-26-000040.md) | [(1.00)](/filings/0001805526-26-000055.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.8](/filings/0001575872-23-001740.md) | [5.1](/filings/0001013762-25-003260.md) | [3.9](/filings/0001575872-24-000532.md) | [3.2](/filings/0001575872-24-000905.md) | [2.8](/filings/0001575872-24-001133.md) | [2.5](/filings/0001213900-25-042977.md) | [1.8](/filings/0001213900-25-042977.md) | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [6.1](/filings/0001575872-23-001740.md) | [5.3](/filings/0001013762-25-003260.md) | [4.2](/filings/0001575872-24-000532.md) | [3.4](/filings/0001575872-24-000905.md) | [3.1](/filings/0001575872-24-001133.md) | [3.3](/filings/0001805526-26-000006.md) | [3.1](/filings/0001213900-25-042977.md) | [5.6](/filings/0000950170-25-108479.md) | [174](/filings/0001193125-25-286660.md) | [122](/filings/0001805526-26-000055.md) | [128](/filings/0001805526-26-000040.md) | [115](/filings/0001805526-26-000055.md) |
| Total assets | $m | [6.2](/filings/0001575872-23-001740.md) | [6.7](/filings/0001013762-25-003260.md) | [5.5](/filings/0001575872-24-000532.md) | [4.8](/filings/0001575872-24-000905.md) | [4.5](/filings/0001575872-24-001133.md) | [4.4](/filings/0001805526-26-000006.md) | [4.2](/filings/0001213900-25-042977.md) | [107](/filings/0000950170-25-108479.md) | [480](/filings/0001193125-25-286660.md) | [307](/filings/0001805526-26-000055.md) | [230](/filings/0001805526-26-000040.md) | [203](/filings/0001805526-26-000055.md) |
| Current liabilities | $m | [0.2](/filings/0001575872-23-001740.md) | [0.7](/filings/0001013762-25-003260.md) | [0.3](/filings/0001575872-24-000532.md) | [0.3](/filings/0001575872-24-000905.md) | [0.4](/filings/0001575872-24-001133.md) | [0.6](/filings/0001805526-26-000006.md) | [1.1](/filings/0001213900-25-042977.md) | [5.1](/filings/0000950170-25-108479.md) | [85.5](/filings/0001193125-25-286660.md) | [80.8](/filings/0001805526-26-000055.md) | [91.7](/filings/0001805526-26-000040.md) | [94.8](/filings/0001805526-26-000055.md) |
| Total liabilities | $m | [0.2](/filings/0001575872-23-001740.md) | [0.9](/filings/0001013762-25-003260.md) | [0.5](/filings/0001575872-24-000532.md) | [0.5](/filings/0001575872-24-000905.md) | [0.5](/filings/0001575872-24-001133.md) | [0.9](/filings/0001805526-26-000006.md) | [1.3](/filings/0001213900-25-042977.md) | [27.6](/filings/0000950170-25-108479.md) | [236](/filings/0001193125-25-286660.md) | [208](/filings/0001805526-26-000055.md) | [220](/filings/0001805526-26-000040.md) | [215](/filings/0001805526-26-000055.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001805526-26-000006.md) | not reported | [21.2](/filings/0000950170-25-108479.md) | [131](/filings/0001193125-25-286660.md) | [127](/filings/0001805526-26-000055.md) | [128](/filings/0001805526-26-000040.md) | [121](/filings/0001805526-26-000055.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.4](/filings/0000950170-25-108479.md) | [0.3](/filings/0001193125-25-286660.md) | [0.1](/filings/0001805526-26-000055.md) | [0.0](/filings/0001805526-26-000040.md) | [0.0](/filings/0001805526-26-000055.md) |
| Shareholders' equity | $m | [6.0](/filings/0001575872-24-001133.md) | [5.8](/filings/0001805526-26-000006.md) | [5.0](/filings/0001193125-25-286660.md) | [4.3](/filings/0001193125-25-286660.md) | [4.0](/filings/0001193125-25-286660.md) | [3.5](/filings/0001805526-26-000055.md) | [2.8](/filings/0001805526-26-000055.md) | [79.6](/filings/0001805526-26-000055.md) | [244](/filings/0001193125-25-286660.md) | [99.3](/filings/0001805526-26-000055.md) | [10.2](/filings/0001805526-26-000055.md) | [(12.0)](/filings/0001805526-26-000055.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.6) d](/filings/0001575872-24-001133.md) | [(0.7) d](/filings/0001013762-25-003260.md) | [(1.1)](/filings/0001213900-25-042977.md) | [(0.7) d](/filings/0000950170-25-108479.md) | [(0.4) d](/filings/0001193125-25-286660.md) | [(0.2) d](/filings/0001805526-26-000006.md) | [(0.8)](/filings/0001805526-26-000040.md) | [(1.3) d](/filings/0001805526-26-000055.md) | [(5.0) d](/filings/0001193125-25-286660.md) | [(10.9) d](/filings/0001805526-26-000006.md) | [(9.8)](/filings/0001805526-26-000040.md) | [(4.3) d](/filings/0001805526-26-000055.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001575872-24-001133.md) | [0.0 d](/filings/0001013762-25-003260.md) | [0.0](/filings/0001213900-25-042977.md) | [0.0 d](/filings/0000950170-25-108479.md) | [0.0 d](/filings/0001193125-25-286660.md) | [0.0 d](/filings/0001805526-26-000006.md) | not reported | not reported | [0.0 d](/filings/0001193125-25-286660.md) | [0.0 d](/filings/0001805526-26-000006.md) | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001805526-26-000006.md) | [0.0](/filings/0001805526-26-000040.md) | [0.0 d](/filings/0001805526-26-000055.md) | not reported | not reported | [10.5](/filings/0001805526-26-000040.md) | [0.0 d](/filings/0001805526-26-000055.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2022-09-30) | period not labelled (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.8](/filings/0001575872-23-001740.md) | [7.1](/filings/0001575872-24-000532.md) | [7.1](/filings/0001575872-24-000905.md) | [9.2](/filings/0001575872-24-001133.md) | [1.4](/filings/0001213900-25-042977.md) | [9.7](/filings/0000950170-25-108479.md) | [9.8](/filings/0001193125-25-286660.md) | [10.0](/filings/0001805526-26-000040.md) | [19.3](/filings/0001805526-26-000055.md) | [29.5](/filings/0001805526-26-000006.md) | [26.3](/filings/0001805526-26-000040.md) | [27.4](/filings/0001805526-26-000055.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,997,790 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001805526-26-000055.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.